DOCSLIB.ORG

BIOE 273, MED 273 Biodesign for Mobile Health Fall Quarter – Academic Year 2016/2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BIOE 273, MED 273 Biodesign for Mobile Health Fall Quarter – Academic Year 2016/2017 BIOE 273, MED 273 Biodesign for Mobile Health Fall Quarter – Academic Year 2016/2017 This Biodesign’s experiential, multidisciplinary and diverse three‑unit course focuses on the rapidly developing mobile health sector, with emphasis on the process of creating innovative technology solutions to mobile health needs. In this context, mobile health (mHealth) refers broadly to the delivery of health services and information enabled by mobile apps and technologies including sensors, wearables, mobile phones and other connected, mobile devices. Innovations in this sector seek to improve access to affordable, high‑quality care by enabling consumers to take greater control of their health, shifting the focus from “sick care” to “health improvement” and prevention, creating new ways to manage aging and chronic conditions, moving care from the hospital into the home, or improving treatment options by providing measurable clinical outcomes for individuals and populations. Opportunities exist across the entire cycle of care, from wellness to acute and chronic diseases to care at the end of life. BioE 273 / Med 273 “Biodesign for Mobile Health” draws attention to mobile health as an area of needs (of patients, consumers and caregivers). The goal is to teach the innovation process that meets them through the understanding of relevant and timely industry‑wide perspectives. To this goal, the course examines the forces that are driving needs in the space, discusses the opportunities and challenges that characterize the mobile health innovation landscape, and highlights the technologies, design considerations, policy initiatives, delivery models and companies that are enabling the new service and information delivery paradigms. Over 50 expert guests from the mobile health industry and entrepreneurial community join Faculty and researchers from Stanford University and others as panelists, speakers and mentors in interactive sessions and team activities. In a collaborative environment, students work in project teams with mentors and coaches, leading to a 얈inal presentation of their needs and concept solutions to an expert panel. The awarded best‑in‑class team receives an award and the opportunity to continue their project during the “Biodesign for Mobile Health Immersion Program.” IMPORTANT: E nrollment in Biodesign for Mobile Health is by application only Applications for Biodesign for Mobile Health will be in two rounds. First round of applications ● Opens: May 16; Closes: September 3 ● Up to 28 Spots Available Second round of applications ● Opens: September 4; Closes: September 26 ● Up to 8 Spots Available APPLY ONLINE AT: http://tinyurl.com/bioe273 BIOE 273/MED 273 Course Directors: Marta Gaia Zanchi, Ph.D. Paul Yock, M.D. Units: 3 units Day/Time: Wednesdays 3:30 – 6:20 pm 3:30 – 4.20 pm Lecture, Team Activity 4:30 – 5:50 pm Interactive Panel 5:50 – 6.20 pm Networking Location: Peter Wallenberg Learning Theater, Room 124 Building 160, Main Quad 450 Serra Mall, Stanford, CA 94305 Course Reader: No textbook required. Online resources to be provided via Canvas. Dates: The seminar will be held each Wednesday of the quarter (except during holidays) starting on September 28, 2016 and ending on December 7, 2016. Following regular class hours on December 7, a ceremony is held at Biodesign awarding the top students’ projects. All students are expected to attend a minimum of 9 class meetings and the awarding ceremony. Goals for the Course ● Understand the forces driving the need for mobile health ● Provide an overview of the mobile health industry ● Explore selected enabling technologies, design approaches and delivery methods ● Learn about the Biodesign innovation process in the context of mobile health ● Highlight interdependencies and synergies between disciplines ● Provide exposure to industry experts who can help clarify career paths ● Inspire and foster entrepreneurship opportunities in mobile health Topics Covered ● Mobile Health Needs ● Enabling Technologies ● Designing for Health ● Policy ● Business Models ● Financing ● Entrepreneurship ● Corporate Strategies 2 Biodesign for Mobile Health, 2016/2017 Rev: Summer 2016 BIOE 273/MED 273 Student Responsibilities The Biodesign for Mobile Health course is taught by a combination of Faculty from Stanford University and other Academic Institutions as well as expert guests from the Mobile Health industry and entrepreneurial community. As such, the course provides a unique chance to gain real‑world insights, build a relevant network and learn about career paths in the space. Grading will be based on: ● Attendance ● Readings ● Class participation ● Completion of a team‑based class project Absences No more than one unexcused absence is permitted. A second absence may be permitted with written justi얈ication by the student. Two or more unexcused absences will lead to a No CR grade. Grading and Deliverables 3 Units – CR/No CR or Letter Grade Students may elect to attend the course for CR/No Cr or for a Letter Grade. In addition to attending classes (9 of 10), completing readings and participate actively in the classroom environment, students are required to form teams and to complete a class project exploring a need in the Mobile Health 얈ield. These projects may be chosen from a list of faculty‑recommended needs, or, students are welcome to suggest projects of their choice (with instructor pre‑approval). Requirements to ful얈ill a class project: ● Registered students form teams of 4‑5 students to work on their project. o Teams are formed and announced by Course Faculty on the 얈irst day of class. ● Teams work on projects, also with the support by assigned mentors and Need Coaches, both during and outside class. o The process of pairing teams with mentors and Need Coaches is done by Course Faculty and is generally completed by mid‑October. ● Teams update each other, faculty and guests on their progress during class. o The goal is to allow students to receive advice, feedback on process and 얈indings. ● Teams submit a 150‑words paragraph describing the central project idea by 11 pm on Monday, October 10 . A list of possible project ideas is provided to teams during class. o Project ideas not included in the list need to be approved by Course Faculty Grading will be based on: ● A 1‑page summary paper on the project idea, due Friday, December 2 . ● A 10‑15 slide presentation delivered on Wednesday, December 7. The slide deck (powerpoint or pdf) must be submitted no later than noon on Sunday, December 4 . 3 Biodesign for Mobile Health, 2016/2017 Rev: Summer 2016 BIOE 273/MED 273 The key criteria we are looking for in the projects deliverables are ( 1) understanding of the mobile health need and (2) representation of the biodesign innovation p rocess. The 얈irst is paramount and involves a clearly formulated and well researched mobile health need. The second involves a strong process towards concept solution generation and selection ( originality and potential for impact will be praised), with attention to opportunities for development ( feasibility ) and delivering strategies ( sustainability , as can be achieved via appropriate regulatory, marketing and business strategies). By focusing on the need and how students have applied the innovation process to address it, teams will demonstrate that their solution has a reasonable likelihood of being accepted by all stakeholders. In evaluating the projects, we will place greater emphasis on evaluating the caliber of the research performed and what students have learned rather than the actual solutions and strategies they have devised. High quality of content and deliverables is most important, and is always preferred over quantity with limited insight. Additional information on the 얈inal presentations and past examples of project papers and slides will be distributed in November. All deliverables should be submitted on Canvas for review by the lead Course Director, Marta Gaia Zanchi. Teams who present their ideas in class on December 7 and are awarded best by a judging panel will be eligible to register for additional credit during the Winter quarter, to continue exploring their ideas with the help of mentors including Faculty and experts from the Mobile Health industry. 4 Biodesign for Mobile Health, 2016/2017 Rev: Summer 2016 BIOE 273/MED 273 Course Materials All course materials are found on the Canvas website. Guest lecturer biographies and presentation slides from the speakers who give consent will also be posted on Canvas. Contact Information Course Directors Marta Gaia Zanchi, Ph.D. [email protected] Paul Yock, M.D. Assistant: Annette Ewanich, [email protected] Teaching Assistant Neil R. Gandhi [email protected] A course offered by: 318 Campus Drive, Clark Center, Rm E100, Stanford University, CA 94305‑5428 Website : http://biodesign.stanford.edu Tel: 650‑736‑1160 Advisory Board Members We acknowledge the strategic input of the generous members of our Advisory Board, who inform course Directors on relevant industry topics, advise course structure decisions and recommend key expert speakers. Yogen Dalal, PhD Partner Emeritus, May얈ield. Chairman and co‑founder, Glooko Mark Zdeblick, PhD Co‑Founder, Chief Technology Of얈icer, Proteus Digital Health Cheryl Cheng , MBA Partner, BlueRun Ventures. Co‑Founder, BrandGarage Asha Nayak, MD, PhD Global Medical Director, Intel Corporation Paul Wang, MD Professor of Medicine and of Bioengineering, Stanford University Michael McConnell, MD Head, Cardiovascular Health Innovations, Verily Life Sciences 5 Biodesign
Load more

Recommended publications
  • In an Ehr World
    10.5 IDEAS TO THRIVE IN AN EHR WORLD PUBLISHED BY “The future is already here - it’s just not evenly distributed.” William Gibson (in 1993) INTRODUCTION: Most of our industry’s attention thus far has gone towards implementing electronic health record systems (EHRs). While it seems to be end in itself, rolling out an EHR is one of the many building blocks towards a digital platform that can change how healthcare is delivered. This paper gives 10.5 ideas that can help doctors, clinicians and administrators save time and therefore money in an EHR world. These ideas exist as early signals in our industry. It’s only a matter of time when these signals amplify to become an accepted norm. ABOUT THE AUTHOR: Praveen Suthrum, (Twitter: @suthrum) Praveen Suthrum is the President and Co-founder of NextServices, a healthcare management and technology company. He works on product design and technology. He contributed to The New Age of Innovation (by C.K. Prahalad and M.S. Krishnan) that was named the best book on innovation by The Economist in 2008. He has an MBA from The Ross School of Business at University of Michigan and attended Singularity University. Praveen loves to trek and has most recently climbed Mt. Kilimanjaro. 1 Get your records through a mobile cloud. Look at patients, not a computer. Your bank account, trading account, email, family pictures are all on the cloud - you can even access them through your iPad. More than the money required to keep servers running, taking back-ups and engaging IT staff, server-based systems waste time that can be spent elsewhere.
    [Show full text]
  • Artificial Intelligence: the Key to Unlocking Novel Real-World Data?
    Artificial Intelligence: The Key to Unlocking Novel Real-World Data? While Artificial intelligence stands to make significant contributions to clinical research due to its unparalleled ability to translate unstructured data into real-world evidence (RWE), significant challenges remain in achieving regulatory-grade evidence. By Michele Cleary 16 | March/April 2019 Value & Outcomes Spotlight Artificial intelligence (AI) is revolutionizing healthcare services. From improving disease detection to supporting treatment decision making, AI has become ubiquitous in care delivery. Now AI is poised to transform the drug and device development process, helping researchers refine the approval process and significantly cutting both the time and the expense needed to bring products to market. While AI has long been used to facilitate recruitment of study subjects, optimize study design, and support patient adherence to study protocols, AI’s greatest contribution to clinical research may still be on the horizon— unlocking the data richness that lies within the mountains of novel real- world data (RWD) sources. This article explores how AI may improve clinical research through its ability to better translate RWD into real-world evidence (RWE), thus providing more valid evidence of clinical benefits and risks. Dan Riskin, MD, of Verantos, Rich Glinklich, MD of OM1, and Sebastian Schneeweiss, MD of Aetion all shared their valuable insights into how AI is transforming clinical research. THE SEARCH FOR REGULATORY-GRADE DATA With innovations in digital data, HEOR researchers are facing explosive growth in novel RWD sources. But as researchers move from traditional RWD sources (eg, registries and claims data) to these novel data sources, unstructured data present a significant opportunity and challenge.
    [Show full text]
  • Ontario Biology Day 2014 Abstracts
    Ontario Biology Day 2014 University of Toronto Mississauga March 22-23, 2014 Abstracts We would like to thank our sponsors Titanium Sponsor Platinum Sponsors Office of the VP Research, UTM Office of the Dean University of Toronto Mississauga Fluid Surveys 2 Gold Sponsors Canadian Society of Zoologists 3 Ontario Biology Day 2014 March 22-23 University of Toronto Mississauga Conference Organizing Committee Daniel Almeida Lisa Cheung Yen Du Sanja Hinic-Frlog Aaron LeBlanc Fiona Rawle Audrey Reid Christoph Richter Published by: University of Toronto Mississauga Department of Biology 3359 Mississauga Road Mississauga, ON L5L 1C6 http://www.utm.utoronto.ca/biology Twitter: @UTMBiology Copyright 2014 Logo Design by Scott Winrow 4 Welcome to Ontario Biology Day 2014 at the University of Toronto Mississauga! We are thrilled to welcome you to the 27th annual Ontario sponsors by signing the “Thank you to our sponsors” card at the Biology Day (OBD) undergraduate student research conference. registration desk. And importantly, we would like to extend a On behalf of the Department of Biology at the University of thank you to all of the supervisors and students that have Toronto Mississauga, we wish you the best of success in travelled to the conference this weekend to present their work presenting your research to your peers this weekend, and and share in this conference experience. This conference is a congratulate you on your achievement in undergraduate biology celebration of your research, and we congratulate you on your research. hard work and research achievements. OBD is an annual event that showcases and celebrates biology Sincerely, research conducted by undergraduate students across Ontario.
    [Show full text]
  • Expanding the Use of Real- World Evidence in Regulatory and Value-Based Payment Decision-Making for Drugs and Biologics July 2019 LEADERSHIP William H
    Expanding the Use of Real- World Evidence in Regulatory and Value-Based Payment Decision-Making for Drugs and Biologics July 2019 LEADERSHIP William H. Frist, M.D. Mark McClellan, M.D., Ph.D. Former U.S. Senate Majority Leader Robert J. Margolis Professor of Business, Medicine, Senior Fellow, Bipartisan Policy Center and Policy, Duke University Founding Director, Duke-Margolis Center for Robert Califf, M.D., Ph.D. Health Policy Professor of Medicine, Donald F. Fortin, M.D., Former Administrator, Centers for Medicare and Professor of Cardiology, Duke School of Medicine Medicaid Services Member, Duke Clinical Research Institute Former Commissioner, Food and Drug Administration Former Commissioner, Food and Drug Administration Andrew von Eschenbach, M.D. President, Samaritan Health Initiatives Former Commissioner, Food and Drug Administration Former Director, National Cancer Institute Senior Fellow, Bipartisan Policy Center STAFF G. William Hoagland Janet M. Marchibroda Senior Vice President Fellow, Bipartisan Policy Center CONSULTANTS Gregory Daniel, Ph.D., R.Ph. Morgan Romine Deputy Director, Duke Margolis Center for Research Director, Duke Margolis Center for Health Policy Health Policy Clinical Professor, Fuqua School of Business, Mark Segal, Ph.D., FHIMSS Duke University Principal, Digital Health Policy Advisors ACKNOWLEDGMENTS The Bipartisan Policy Center would like to thank the Jayne Koskinas Ted Giovanis Foundation for Health and Policy for their generous support for this project. BPC would like to thank the leadership of this effort, including Senator Bill Frist, Dr. Rob Califf, Dr. Mark McClellan, and Dr. Andrew von Eschenbach, for their guidance, as well as Morgan Romine, Gregory Daniel, Mark Segal, and Ann Gordon who contributed to the development of this report.
    [Show full text]
  • Programs Director for IT Services Research and Where He Created the Global IT Service Research and Innovation Institute, SRII (
    SRII China Summit 2015 Theme: Innovating Digital Economy — Advancing Industry 4.0 Transformation Time： March 4-6, 2015 Venue: Shanghai, China Background Advanced Industrial Technology Research Institute in Shanghai Jiao Tong University(AITRI) is excited to team up with Service Research & Innovation Institute (SRII) to host 2015 SRII China Summit：Innovating Digital Economy— Advancing Industry 4.0 Transformation from March 4th to 6th, 2015 in Shanghai Lingang New City. Senior leaders from key industry sectors, academia, research, government and professional organizations in India, Asia, Europe and USA will be invited to discuss IOT, big data, Industry 4.0, Smart-Healthcare, Education and other related topics. The summit is well aligned with innovation agenda for industry upgrade and emerging market in Shanghai as well as in China. SRII (Service Research & Innovation Institute) is a global ICT Research & Innovation Institute with a mission to drive ICT Innovation (Cloud computing, Mobile Services, Big data analytics, Security, Social) for major sectors of service economy (government, education, healthcare, transportation, manufacturing, agriculture & food safety, and etc) around the world. SRII member include senior leaders from industry, academia, research and government organizations from around the world. Advanced Industrial Research Institute (AITRI) promotes the emerging pillar industries transferred from the high-tech research findings by maximizing the market value of the industrial technologies. AITRI is building an international
    [Show full text]
  • Obituary: Thomas Henry Kunz (1938–2020)
    applyparastyle "fig//caption/p[1]" parastyle "FigCapt" applyparastyle "fig" parastyle "Figure" Journal of Mammalogy, 101(6):1752–1780, 2020 DOI:10.1093/jmammal/gyaa100 Published online November 20, 2020 Obituary: Thomas Henry Kunz (1938–2020) Dr. Thomas Henry Kunz (Fig. 1), an internationally rec- Tom’s early interest in science was sparked by a fifth-grade ognized expert on the ecology and behavior of bats and teacher who had her students undertake a project raising silk- Professor at Boston University, passed away on 13 April 2020 worms. Tom commented in his autobiography that, “This ex- in Dedham, Massachusetts, at the age of 81 as the result of perience left an indelible impression on me, and highlights the complications from COVID-19. Tragically, Dr. Kunz’s career power of observational learning” (197:150). Tom also had an was cut short when he was the victim of a pedestrian–auto- early experience with a bat colony inside a stove in a fishing mobile accident on 26 October 2011. He was struck crossing cabin. After chasing and removing the bats from the cabin, a street in Toronto, Canada, while participating in his favorite Tom recalled, “being fascinated by these little winged ‘crit- annual meeting, that of the North American Society for Bat ters’” (197:150). Tom became an Eagle Scout and remembered Research (NASBR). He never fully recovered from the head taking great pride in earning his nature merit badge, which re- trauma suffered and was not able to live independently, but quired learning the names of local plants and animals. When he enjoyed daily visits from his wife and frequent visits from Tom graduated from high school, he was planning to attend his children and grandchildren as well as friends.
    [Show full text]
  • Top 100 AI Leaders in Drug Discovery and Advanced Healthcare Introduction
    Top 100 AI Leaders in Drug Discovery and Advanced Healthcare www.dka.global Introduction Over the last several years, the pharmaceutical and healthcare organizations have developed a strong interest toward applying artificial intelligence (AI) in various areas, ranging from medical image analysis and elaboration of electronic health records (EHRs) to more basic research like building disease ontologies, preclinical drug discovery, and clinical trials. The demand for the ML/AI technologies, as well as for ML/AI talent, is growing in pharmaceutical and healthcare industries and driving the formation of a new interdisciplinary industry (‘data-driven healthcare’). Consequently, there is a growing number of AI-driven startups and emerging companies offering technology solutions for drug discovery and healthcare. Another important source of advanced expertise in AI for drug discovery and healthcare comes from top technology corporations (Google, Microsoft, Tencent, etc), which are increasingly focusing on applying their technological resources for tackling health-related challenges, or providing technology platforms on rent bases for conducting research analytics by life science professionals. Some of the leading pharmaceutical giants, like GSK, AstraZeneca, Pfizer and Novartis, are already making steps towards aligning their internal research workflows and development strategies to start embracing AI-driven digital transformation at scale. However, the pharmaceutical industry at large is still lagging behind in adopting AI, compared to more traditional consumer industries -- finance, retail etc. The above three main forces are driving the growth in the AI implementation in pharmaceutical and advanced healthcare research, but the overall success depends strongly on the availability of highly skilled interdisciplinary leaders, able to innovate, organize and guide in this direction.
    [Show full text]
  • BIOE 273, MED 273 Biodesign for Mobile Health Fall Quarter – Academic Year 2017/2018
    BIOE 273, MED 273 Biodesign for Mobile Health Fall Quarter – Academic Year 2017/2018 Rev. 05.14.2017 Health care is facing significant cross-industry challenges and opportunities created by a number of factors including: an increasing need for improved access to affordable, high-quality care; a growing demand from consumers for greater control of their health and health data; a shift in focus from “sick care” to prevention and health optimization; aging demographics and the increased burden of chronic conditions; and new emphasis on real-world, measurable health outcomes for individuals and populations. Moreover, the delivery of health information and services is no longer tied to traditional “brick and mortar” hospitals and clinics: it has increasingly become "mobile," enabled by apps, sensors, wearables, and other mobile devices, as well as by the data that these technologies generate. This multifactorial transformation presents opportunities for innovation across the entire cycle of care, from wellness, to acute and chronic diseases, to care at the end of life. But how does one approach innovation in mobile health to address these health care challenges while ensuring the greatest chance of success? At Stanford Biodesign, we believe that innovation is a process that can be learned, practiced, and perfected; and, it starts with a need. In Biodesign for Mobile Health, students will learn about mobile health and the Biodesign needs-driven innovation process from over 50 industry experts. Over the course of ten weeks, these speakers join the teaching team in a dynamic classroom environment that includes lectures, panel discussions, and breakout sessions. These experts represent startups, corporations, venture capital firms, accelerators, research labs, health organizations, and more.
    [Show full text]
  • ISPOR 2019 the Professional Society for Health Economics and Outcomes Research
    ISPOR 2019 The professional society for health economics and outcomes research May 18-22, 2019 Rapid. Disruptive. Innovative: A New Era in HEOR Program and Schedule of Events #ISPORAnnual NETWORK: ISPOR2019 / WI-FI PASSWORD: HEALTHCORE www.ispor.org ISPOR 2019 May 18-22 Rapid. Disruptive. Innovative: A New Era in HEOR Table of Contents ISPOR 2019 AGENDA AT A GLANCE 4 CONFERENCE PROGRAM COMMITTEE 9 CONFERENCE SPONSORS 10 PLENARY SESSIONS 11 SCHEDULE OF EVENTS l SATURDAY, MAY 18 14 l SUNDAY, MAY 19 17 l MONDAY, MAY 20 21 l TUESDAY, MAY 21 29 l WEDNESDAY, MAY 22 37 INVITATIONAL GROUP MEETINGS 42 POSTER OVERVIEW 46 EXHIBIT PROGRAM OVERVIEW 47 EXHIBITOR LISTING 48 POSTER AND EXHIBIT HALL FLOOR PLAN 49 2019 ISPOR AWARDS PROGRAM 50 KEY INFORMATION 62 CONFERENCE ROOMS FLOOR PLAN 63 www.ispor.org 3 ISPOR 2019 May 18-22 | New Orleans, LA, USA ISPOR 2019 Agenda-at-a-Glance Saturday, May 18, 2019 7:00AM - 7:00PM REGISTRATION HELP DESK HOURS 8:00AM - 12:00PM SHORT COURSE MORNING SESSION 8:00AM - 5:00PM SHORT COURSE FULL DAY 1:00PM - 5:00PM SHORT COURSE AFTERNOON SESSION 5:30PM - 6:30PM EDUCATIONAL SYMPOSIUM Sunday, May 19, 2019 7:00AM - 7:00PM REGISTRATION HELP DESK HOURS 8:00AM - 10:00PM EXHIBITOR MOVE-IN 8:00AM - 12:00PM SHORT COURSE MORNING SESSION 12:00PM - 6:00PM SPEAKER READY ROOM HOURS 1:00PM - 5:00PM SHORT COURSE AFTERNOON SESSION 5:00PM - 7:00PM ISPOR STUDENT RESEARCH COMPETITION 5:30PM - 6:30PM EDUCATIONAL SYMPOSIUM 6:30PM - 7:30PM ISPOR PRESIDENTIAL RECEPTION (BY INVITATION ONLY) 7:00PM - 8:00PM ISPOR STUDENT & FACULTY ICEBREAKER RECEPTION
    [Show full text]
  • Expanding the Use of Real- World Evidence in Regulatory and Value-Based Payment Decision-Making for Drugs and Biologics August 2019 LEADERSHIP William H
    Expanding the Use of Real- World Evidence in Regulatory and Value-Based Payment Decision-Making for Drugs and Biologics August 2019 LEADERSHIP William H. Frist, M.D. Mark McClellan, M.D., Ph.D. Former U.S. Senate Majority Leader Robert J. Margolis Professor of Business, Medicine, Senior Fellow, Bipartisan Policy Center and Policy, Duke University Founding Director, Duke-Margolis Center for Robert Califf, M.D., Ph.D. Health Policy Professor of Medicine, Donald F. Fortin, M.D., Former Administrator, Centers for Medicare and Professor of Cardiology, Duke School of Medicine Medicaid Services Member, Duke Clinical Research Institute Former Commissioner, Food and Drug Administration Former Commissioner, Food and Drug Administration Andrew von Eschenbach, M.D. President, Samaritan Health Initiatives Former Commissioner, Food and Drug Administration Former Director, National Cancer Institute Senior Fellow, Bipartisan Policy Center STAFF G. William Hoagland Janet M. Marchibroda Senior Vice President Fellow, Bipartisan Policy Center CONSULTANTS Gregory Daniel, Ph.D., R.Ph. Morgan Romine Deputy Director, Duke Margolis Center for Research Director, Duke Margolis Center for Health Policy Health Policy Clinical Professor, Fuqua School of Business, Mark Segal, Ph.D., FHIMSS Duke University Principal, Digital Health Policy Advisors ACKNOWLEDGMENTS The Bipartisan Policy Center would like to thank the Jayne Koskinas Ted Giovanis Foundation for Health and Policy for their generous support for this project. BPC would like to thank the leadership of this effort, including Senator Bill Frist, Dr. Rob Califf, Dr. Mark McClellan, and Dr. Andrew von Eschenbach, for their guidance, as well as Morgan Romine, Gregory Daniel, Mark Segal, and Ann Gordon who contributed to the development of this report.
    [Show full text]
  • Academic Year 2012–2013
    report card academic year 2012–2013 Executive Summary Alberta, Canada, The lifeblood of all universities is human curiosity, imagination, creativity, and action, borne out of a genuine desire to know and understand the world and and the world humanity more clearly and accurately. These ideals may be lofty but the results are tangible, with measurable benefits befalling not only students, staff, and benefit from the faculty, but also the broader communities of which they are a part. Alberta, Canada, and the world benefit from the learning and discovery that occurs daily learning and at the University of Alberta. discovery that What are those benefits? Advances in knowledge, better health, increased social cohesion, and economic growth. A highly skilled workforce. Spinoff companies. occurs daily at Leaders and innovators with vision and skill. A large majority of U of A graduates choose to live and build their careers within the province. Both the historical and the University the current record show that U of A alumni and faculty have provided essential leadership in every sector of society—whether we speak of the province’s of Alberta. vibrant theatre community, its strengths in health care, or its world-leading K–12 educational system. Given that Alberta projects a labour shortage of 114,000 workers over the next decade—62,000 of whom will require a post-secondary education—it is clear that the U of A is filling an essential role in society. We are doing so because of our sustained commitment to excellence and to our goal of building a great university equal to the best public universities in the world.
    [Show full text]
  • Statement of Dan Riskin Founder, Health Fidelity Consulting Faculty, Stanford University
    Statement of Dan Riskin Founder, Health Fidelity Consulting faculty, Stanford University Before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Communications & Technology and Subcommittee on Healthcare Hearing on “21st Century Technology for 21st Century Cures” July 17, 2014 Post-hearing Questions Testimony of Dan Riskin Committee on Energy and Commerce Subcommittee on Communications & Technology and Subcommittee on Healthcare Questions from the Honorable Joe Pitts 1. The characteristics of big data - Velocity, Variety and Volume - are often minimized when used for healthcare due to the complexity and restraints of HIPAA. Does Congress need to take a fresh look at our privacy laws to enable patients to become “data donors”, giving consent to allow their medical data to be shared for longitudinal research. This question strikes at the heart of how clinical data can be valuable not just for daily patient care, but also for making the practice of healthcare more effective and efficient. Congress could significantly benefit the nation if it took a fresh look at privacy laws to examine how patients can be empowered to consent to specific uses of their data to advance medicine. The big data opportunity to advance the practice of healthcare is powerful. Based on direction from Congress, an immense quantity of clinical data is now being collected. There is an opportunity to mine these data to understand more effective and efficient clinical approaches that leverage clinical observations, genetic information, consumer biometrics, and consumer observations. Research has been hindered by inability to consistently extract full clinical data from the electronic health record (interoperability) and inability of patients to consistently authorize use of their data for such research (consent).
    [Show full text]